- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04045483
Virtual Reality Based Cognitive Training Program in Mild Cognitive Impairment (VRMCI)
August 2, 2019 updated by: Inha University Hospital
A Randomized Controlled Crossover Trial to Assess Efficacy of Virtual Reality Based Cognitive Training Program in Mild Cognitive Impairment
This study evaluates efficacy and safety of virtual reality (VR)-based cognitive training program in amnestic mild cognitive impairment.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This study is a single-blind, randomized, controlled, two-period crossover trial.
The intervention is done twice a week for 6 weeks.
There are two arms.
During the first period, participants were randomized to receive either VR-based cognitive training or usual care.
After a 2-week washout period, the groups were crossed over to receive the alternative treatment for 6 weeks.
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Seong Hye Choi, MD, PhD
- Phone Number: 82 32 890 3659
- Email: seonghye@inha.ac.kr
Study Contact Backup
- Name: Hye Lan Na, RN
- Phone Number: 82 32 890 1119
- Email: nhyelan@hanmail.net
Study Locations
-
-
-
Incheon, Korea, Republic of, 22332
- Recruiting
- Inha University Hospital
-
Contact:
- Seong Hye Choi, MD, PhD
- Email: seonghye@inha.ac.kr
-
Contact:
- Hye Lan Na, RN
- Email: nhyelan@hanmail.net
-
Seoul, Korea, Republic of
- Not yet recruiting
- Ewha Womans University Mokdong Hospital
-
Contact:
- Jee Hyang Jeong, MD, PhD
-
Principal Investigator:
- Jee Hyang Jeong, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 50-85
- A memory complaint by a participant or caregiver
- Objective memory decline as defined by a delayed recall score of verbal learning test or logical memory worse than 1.0 standard deviations (SD) below age and education-adjusted normative mean
- MMSE score better than1.5 SD below age and education-adjusted normative means
- Global Clinical Dementia Rating (CDR) scale of 0.5 and memory score of CDR 0.5 or 1
- Preserved activities of daily living (ADL), as defined by Korean Instrumental Activities of Daily Living < 0.4
- Not demented
- Hachinski Ischemic Score ≤ 4
- Can read and write Korean
- brain MRI or CT showing no other diseases capable of producing cognitive impairment
- Having a reliable informant who could provide investigators with the requested information.
- Provide written informed consent
Exclusion Criteria:
- Participated in another clinical trial within the past 4 weeks
- Other serious or unstable medical disease such as acute or severe asthma, severe or unstable cardiovascular disease, active gastric ulcer, severe liver disease, or severe renal disease
- A clinically significant laboratory abnormality, such as an abnormal thyroid function test, abnormal low levels of vitamin B12 or folate, and positive syphilis serology
- A primary other neurodegenerative disorder
- Major psychiatric illness such as major depressive disorders
- Drug or alcohol addiction during the past 10 years
- Severe loss of vision, hearing, or communicative disability
- Malignancy within 5 years
- Any conditions preventing cooperation as judged by the study physician
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: VR based cognitive training
Participants perform the VR based cognitive training under the supervision of a research nurse or psychologist for 30 min per session, twice per week, over the 6-week intervention period.
|
The VR-based cognitive training consists of a three-dimensional simulation of home, a mart, bus stop, and street.
It provides an integrative cognitive training experience where participants are required to accomplish some common ADL's in three frequently visited places: home, a supermarket, and bus stop.
|
No Intervention: Usual care
Participants take some medication for risk factors and cognitive impairment and receive health advice as a usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Short form of Literacy Independent Cognitive Assessment from baseline at 6 weeks
Time Frame: 6 weeks
|
Measurement of memory, visuospatial function, language, and executive function The range of score is from 0 to 100.
The higher score means better cognition.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Mini-Mental State Examination from baseline at 6 weeks
Time Frame: 6 weeks
|
Evaluation of global cognition The range of score is from 0 to 30.
The higher score means better cognition.
|
6 weeks
|
Change of Clinical Dementia Rating Scale-Sum of Boxes from baseline at 6 weeks
Time Frame: 6 weeks
|
Evaluation of global cognition The range of score is from 0 to 18.
The higher score means better cognition.
|
6 weeks
|
Change of Quality of life-Alzheimer's disease from baseline at 6 weeks
Time Frame: 6 weeks
|
Evaluation of quality of life The range of score is from 0 to 52.
The higher score means better quality of life.
|
6 weeks
|
Change of Geriatric Depression Scale-15 items from baseline at 6 weeks
Time Frame: 6 weeks
|
Evaluation of mood The range of score is from 0 to 15.
A higher score means more depression.
|
6 weeks
|
Change of Prospective and Retrospective Memory Questionnaire from baseline at 6 weeks
Time Frame: 6 weeks
|
Evaluation of subjective memory The range of score is from 16 to 80.
The higher score means more memory impairment.
|
6 weeks
|
Change of Bayer Activities of Daily Living from baseline at 6 weeks
Time Frame: 6 weeks
|
Evaluation of activities of daily living The range of score is from 1 to 10.
The higher score means worse ADL.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Seong Hye Choi, MD, PhD, Inha University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 7, 2019
Primary Completion (Anticipated)
February 28, 2020
Study Completion (Anticipated)
March 14, 2020
Study Registration Dates
First Submitted
July 26, 2019
First Submitted That Met QC Criteria
August 2, 2019
First Posted (Actual)
August 5, 2019
Study Record Updates
Last Update Posted (Actual)
August 5, 2019
Last Update Submitted That Met QC Criteria
August 2, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-04-029
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
We will decide it later.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
Clinical Trials on Virtual reality based cognitive training
-
Mental Health Services in the Capital Region, DenmarkRigshospitalet, Denmark; University of Copenhagen; TrygFonden, DenmarkRecruitingDepression | Psychotic Disorders | Schizophrenia | Cognitive Impairment | Bipolar Disorder | Schizotypal DisorderDenmark
-
University of Massachusetts, LowellSpaulding Rehabilitation Hospital; Hugo W. Moser Research Institute at Kennedy...Recruiting
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainRecruitingStroke | Cognitive Impairment | Healthy Subjects | HemiparesisBelgium
-
Chungnam National UniversityRecruitingBreast Cancer | Cognitive Dysfunction | Virtual RealityKorea, Republic of
-
Vanderbilt UniversityUniversity of California, San DiegoCompleted
-
St. Jude Children's Research HospitalRecruitingBrain TumorUnited States
-
I-Shou UniversityCompletedQuality of Life | Cognitive Impairment | Virtual RealityTaiwan
-
Baylor Research InstituteCompletedAcquired Brain Injury
-
Universitat Jaume IRecruiting
-
The Hong Kong Polytechnic UniversityCompleted